Research Summary
My work focuses on understanding the mechanisms underlying pancreas development and disease, including diabetes and pancreatic cancer. My research on the role of embryonic signaling pathways in these processes has provided a glimpse into how tight regulation of these signaling events is imperative for proper organogenesis, maintenance of organ function, and prevention of pancreatic cancer. My lab has made important insights into how differentiated cells in the exocrine pancreas, namely duct and acinar cells, undergo a process of dedifferentiation during the early stages of neoplasia that can lead to pancreatic ductal adenocarcinoma (PDA), a particularly lethal cancer in humans.
Research Funding
July 29, 2011 - May 31, 2026 - Defining the role of MafA in islet beta cells , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DK090570
August 15, 2021 - June 30, 2025 - Modulating intrinsic beta cell stress to block diabetes pathogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DK129935
September 20, 2018 - July 31, 2023 - Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: UH3DK120004
May 1, 2015 - July 31, 2023 - Regulation of beta cell identity and dedifferentiation , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DK105831
Education
Biological-Technical Assistant (BTA) School, Bückeburg, Germany, Diploma, 1983-1985, Biology
Albert-Ludwigs University, Freiburg, Germany, Diploma/ Master Ph.D., 1986-1992, Cell & Molecular Biology
Max-Planck-Institute for Immunobiology, Freiburg, Germany, 1992-1995, Developmental Biology
Harvard University, Department of Molecular & Cell Biology and Howard Hughes Medical Institute, Cambridge, MA Postdoctoral Training, 1996-1999, Developmental Biology